Literature DB >> 22126418

Mortality after temporal lobe epilepsy surgery.

Nicola Seymour1, Claudia A Granbichler, Charles E Polkey, Lina Nashef.   

Abstract

PURPOSE: To report mortality, after a longer interval, in a cohort of patients with drug-resistant epilepsy treated by temporal lobe surgery between 1975 and 1995. A previous audit of these patients ending December 1, 1997 observed a standardized mortality ratio (SMR) of 4.5.
METHODS: We analyzed mortality in a cohort of 306 patients with temporal lobe epilepsy (TLE) who underwent temporal lobe resections between December 1, 1975 and December 1, 1995. Deaths occurring after December 1,1997 and until December 1, 2009 were evaluated. Medical records, death certificates, postmortem examination reports, coroner officer's reports, and coroner's inquest reports were sought, and causes of death were ascertained. Sudden unexpected death in epilepsy (SUDEP) cases were identified. KEY
FINDINGS: In 3,569 person-years of follow-up 19 deaths occurred, [SMR 2.00, 95% confidence interval (CI) 1.27-3.13], 14 men (SMR 2.01, 95% CI 1.19-3.39) and 5 women (SMR 1.68, 95% CI 0.70-4.03). On analysis of subgroups, SMRs were significantly elevated in patients with mesial temporal sclerosis (MTS) (SMR 2.50, 95% CI 1.38-4.51), men with MTS (SMR 3.12, 95% CI 1.56-6.25), men with nonspecific lesions (SMR 2.68, 95% CI 1.00-7.09), and right-sided resections in MTS (SMR 3.33, 95% CI 1.39-8.00). During follow-up, six SUDEP cases were observed with a rate of 1/595 person-years. SIGNIFICANCE: In this cohort, the risk for premature death in patients undergoing TLE surgery decreased over time but remained above the standard population. Men had a slightly higher risk than women, as did right-sided resections in MTS, confirming this observation in the original cohort. Although lower, the risk of SUDEP remained. Without up-to-date information on seizure outcome, we were unable to directly relate this to mortality. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2011        PMID: 22126418     DOI: 10.1111/j.1528-1167.2011.03343.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

1.  SUDEP: Sudden Unexpected Death in Epilepsy on Placebo?

Authors:  David C Spencer
Journal:  Epilepsy Curr       Date:  2012-03       Impact factor: 7.500

Review 2.  Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).

Authors:  Melissa J Maguire; Cerian F Jackson; Anthony G Marson; Sarah J Nolan
Journal:  Cochrane Database Syst Rev       Date:  2016-07-19

3.  Surgery for epilepsy.

Authors:  Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton
Journal:  Cochrane Database Syst Rev       Date:  2019-06-25

4.  Living With Epilepsy: It's Not Just a Matter of Quality.

Authors:  Chad Carlson
Journal:  Epilepsy Curr       Date:  2016 Nov-Dec       Impact factor: 7.500

5.  Sudden unexpected death in epilepsy: experience from a tertiary epilepsy centre in Cyprus with review of the literature.

Authors:  S S Papacostas
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

6.  The Difference in Heart Rate Change between Temporal and Frontal Lobe Seizures during Peri-ictal Period.

Authors:  Woo Hyun Son; Woo Sub Hwang; Dae Lim Koo; Kyoung Jin Hwang; Dae Yung Kim; Ji-Hye Seo; Geon-Youb Na; Eun Yeon Joo; Seung Bong Hong; Dae-Won Seo
Journal:  J Epilepsy Res       Date:  2016-06-30

7.  Very Long-Term Outcome of Non-Surgically Treated Patients with Temporal Lobe Epilepsy with Hippocampal Sclerosis: A Retrospective Study.

Authors:  Tsugiko Kurita; Kotaro Sakurai; Youji Takeda; Toru Horinouchi; Ichiro Kusumi
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

8.  Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).

Authors:  Melissa J Maguire; Cerian F Jackson; Anthony G Marson; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2020-04-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.